19th

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…

6 days ago

Frost & Sullivan Hosts 19th Global Growth, Innovation & Leadership Summit in Shanghai

Summit highlights transformational growth strategies, strategic imperatives, and the future of innovation in the Intelligence Revolution SHANGHAI, Sept. 11, 2025…

6 months ago